These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31649528)

  • 1. Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study.
    Xu H; Zou J; Ye X; Han J; Gao L; Luo S; Wang J; Huang C; Yan X; Dai H
    Front Pharmacol; 2019; 10():1112. PubMed ID: 31649528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial.
    Nguyen T; Nguyen TH; Nguyen PT; Tran HT; Nguyen NV; Nguyen HQ; Ha BN; Pham TT; Taxis K
    Front Pharmacol; 2018; 9():656. PubMed ID: 29977205
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
    Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
    BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series Study.
    Schwalm JD; Ivers NM; Bouck Z; Taljaard M; Natarajan MK; Dolovich L; Thavorn K; McCready T; O'Brien E; Grimshaw JM
    JMIR Res Protoc; 2020 Nov; 9(11):e18981. PubMed ID: 33146624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients - a single center prospective randomized controlled study in a Chinese population.
    Du L; Dong P; Jia J; Li Z; Lai L; Yang X; Wang S; Yang X; Li Z; Shang X; Fan X
    Eur J Prev Cardiol; 2016 Jul; 23(10):1077-85. PubMed ID: 26416996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 11. A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial.
    Garcia BH; Giverhaug T; Høgli JU; Skjold F; Småbrekke L
    Pharm Pract (Granada); 2015; 13(2):575. PubMed ID: 26131047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study.
    Gao L; Han Y; Jia Z; Wang P; Zhang M; Ma T; Yan S; Liu H
    Front Pharmacol; 2023; 14():1249636. PubMed ID: 37693909
    [No Abstract]   [Full Text] [Related]  

  • 13. The Effects of Clinical Pharmacist Education on Lifestyle Modifications of Postmyocardial Infarction Patients in South India: A Prospective Interventional Study.
    Sundararajan S; Thukani Sathanantham S; Palani S
    Curr Ther Res Clin Exp; 2020; 92():100577. PubMed ID: 32140190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist Intervention to Improve Medication Adherence in Patients with Acute Coronary Syndrome: The PRIMA-ACS Study.
    Neville HL; Mann K; Killen J; Callaghan M
    Can J Hosp Pharm; 2021; 74(4):350-360. PubMed ID: 34602623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study.
    Sharma KK; Gupta R; Mathur M; Natani V; Lodha S; Roy S; Xavier D
    Indian Heart J; 2016; 68(6):832-840. PubMed ID: 27931556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study.
    Livori AC; Pol D; Levkovich B; Oqueli E
    Int J Clin Pharm; 2023 Jun; 45(3):722-730. PubMed ID: 36940081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit.
    Casper EA; El Wakeel LM; Saleh MA; El-Hamamsy MH
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):44-53. PubMed ID: 30739389
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.